JAN Stock Summary and Trading Ideas (Janone | NASDAQ:JAN)

JanOne Inc is focused on being a clinical-stage pharmaceutical company committed to finding treatments for conditions that cause severe pain and bringing drugs to market with non-addictive pain-relieving properties. One of the Company's goals is to reduce the need for prescriptions for dangerous opioid drugs by treating underlying diseases that cause severe pain. The company operates in two operating segments, namely Biotechnology, and discontinued operations.

Janone trades on the NASDAQ stock market under the symbol JAN.

As of May 10, 2024, JAN stock price declined to $4.01 with 80,902 million shares trading.

JAN has a beta of -0.72, meaning it tends to be less sensitive to market movements. JAN has a correlation of 0.00 to the broad based SPY ETF.

JAN has a market cap of $36.00 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, JAN stock traded as high as $12.28 and as low as $.22.

The top ETF exchange traded funds that JAN belongs to (by Net Assets): VXF, BSVO, CCSO.

JAN has outperformed the market in the last year with a return of +278.3%, while the SPY ETF gained +27.8%. In the last 3 month period, JAN beat the market returning +564.0%, while SPY returned +4.2%. However, in the most recent 2 weeks JAN has underperformed the stock market by returning -21.4%, while SPY returned +2.5%.

JAN support price is $3.66 and resistance is $4.62 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that JAN stock will trade within this expected range on the day.